|
TOP NEWS
POLICY & REGULATION
ENFORCEMENT & COMPLIANCE
LITIGATION
EXPERT ANALYSIS
FDA Moves Leave Peptides In A Legal Gray Zone
While the U.S. Food and Drug Administration has taken a concrete step forward on reclassifying certain peptides, the practical consequence of their interim status cannot be overstated — these substances are no longer designated as posing a significant safety risk, but they have not been affirmatively authorized for compounding, say attorneys at Sheppard.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
Roundup
UK Litigation Roundup: Here's What You Missed In London
By Laura Stewart Liberty
The past week in London has seen lawyer Ian Rosenblatt launch legal action against music mogul Simon Cowell, Boohoo face a fresh investor claim after previously facing allegations that it feigned ignorance of labor abuses in its supply chain, and an ex-Tory MP and his chief of staff sued by their former employer. Here, Law360 looks at these and other new claims in the U.K.
Read full article »
| Save to favorites »
HHS' Ex-GC Committed Ethics Violations, Watchdog Says
By Craig Clough
A watchdog organization filed a complaint Thursday with the U.S. Department of Health and Human Services' Office of Inspector General seeking an investigation into former HHS general counsel Michael Stuart over alleged federal ethics violations, saying it appears he failed to divest from prohibited financial holdings and made prohibited investment purchases after taking office.
Complaint attached |
Read full article »
| Save to favorites »
|